Metformin as a radiosensitiser for pelvic malignancy: A systematic review of the literature. Clifford RE, Gerrard AD, Fok M, Vimalachandran D, et al. Eur J Surg Oncol 2021;47:1252-1257.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Clifford RE, Gerrard AD, Fok M, Vimalachandran D, et al. Metformin as a radiosensitiser for pelvic malignancy: A systematic review of the literature. Eur J Surg Oncol 2021;47:1252-1257.
PMID: 33358075